Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02484404
Brief Title: Phase I/II Study of the Anti-Programmed Death Ligand-1 Antibody MEDI4736 in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Cancers

First Submitted : June 25, 2015
First Submitted that Met QC Criteria : June 25, 2015
First Posted : June 29, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : February 12, 2020
Last Update Posted : February 13, 2020